RegenxBio Inc - Company Profile

Powered by

All the data and insights you need on RegenxBio Inc in one report.

  • Save hours of research time and resources with
    our up-to-date RegenxBio Inc Strategy Report

  • Understand RegenxBio Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

RegenxBio Inc: Premium Databases

RegenxBio Clinical Trials

Determine RegenxBio Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of RegenxBio Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 20+ results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy GDCT0451538 RGX-314 Metabolic Disorders Diabetic Macular Edema; Diabetic Retinopathy Phase II Ongoing, recruiting by invitation RegenxBio Inc
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD GDCT0446471 RGX-314 Ophthalmology Age Related Macular Degeneration; Macular Degeneration; Wet (Neovascular / Exudative) Macular Degeneration Phase II Ongoing, recruiting by invitation RegenxBio Inc
A Phase I/II, First-in-Human, Multi-Center, Open-Label, Dose Escalation and Dose Expansion Trial of RGX-202 in Subjects with Duchenne Muscular Dystrophy GDCT0444613 RGX-202 Genetic Disorders Duchenne Muscular Dystrophy Phase I/II Planned RegenxBio Inc
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of RegenxBio Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code